<DOC>
	<DOCNO>NCT02089256</DOCNO>
	<brief_summary>The study investigate effect glucagon-like peptide receptor 1 agonist , liraglutide , insulin secretion . Study hypothesis : effect liraglutide insulin release may change repeat administration . The effect liraglutide insulin release test use grade glucose infusion test ( GGIT ) healthy volunteer . GGIT perform without medication repeat 12 hour first dose liraglutide 3 week treatment liraglutide .</brief_summary>
	<brief_title>Effect Repeated Administration Liraglutide Insulinogenic Indices</brief_title>
	<detailed_description />
	<mesh_term>Liraglutide</mesh_term>
	<criteria>Weight 50100 kg Chronic disease Concomitant drug use Pregnancy lactation Fasting glucose &gt; 6 mmol/L .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>